Algorithmic bias in clinical decision support systems presents both ethical imperatives and regulatory risks. Healthcare organizations must implement rigorous bias assessment methodologies to ensure AI systems support equitable care delivery.

Bias in healthcare AI can manifest through multiple pathways: training data that reflects historical disparities, feature selection that proxies for protected characteristics, optimization objectives that prioritize aggregate accuracy over subgroup performance, and deployment contexts that differ from development environments.

Our structured methodology for bias assessment encompasses four phases: data audit, model evaluation, deployment monitoring, and continuous improvement. Each phase addresses distinct aspects of algorithmic fairness while maintaining operational feasibility.

Data audits examine training and validation datasets for representation, label quality, and feature distributions across demographic groups. This phase identifies potential bias sources before model development or during vendor evaluation.

Model evaluation applies fairness metrics appropriate to the clinical context. Different metrics suit different use cases—predictive parity may matter for screening tools while equalized odds may be essential for diagnostic aids. Organizations should define acceptable fairness thresholds before evaluation.

Deployment monitoring extends bias assessment beyond pre-deployment testing. Real-world performance often diverges from validation results, and ongoing monitoring can detect emergent disparities that pre-deployment testing missed.

Continuous improvement closes the loop between monitoring and model updates. Organizations should establish processes for addressing detected bias, including temporary usage restrictions, model retraining, and deployment adjustments.

Regulatory frameworks increasingly expect documented bias assessments. The FDA’s guidance on AI/ML-based software, OCR enforcement priorities, and state-level algorithmic accountability laws all point toward bias assessment as a compliance expectation.